
Topical steroid withdrawal remains a controversial topic in the dermatology field, given the lack of necessary data.
Ian Myles, MD, MPH, is a staff clinician from the Epithelial Therapeutics Unit in NIAID’s Laboratory of Clinical Immunology and Microbiology.

Topical steroid withdrawal remains a controversial topic in the dermatology field, given the lack of necessary data.

This interview with Ian Myles, MD, MPH, highlights his team’s recent findings on identifying dermatitis related to topical steroid withdrawal (TSW) versus atopic dermatitis.